Peer Activate: Trial of Peer-Delivered Behavioral Activation for Methadone Adherence (HEAL Together)
Substance-Related Disorders, Opioid Medication Assisted Treatment, Opioid Use Disorder
About this trial
This is an interventional treatment trial for Substance-Related Disorders focused on measuring Disease, Substance-Related Disorders, Opioid-Related Disorders, Mental Disorders
Eligibility Criteria
Inclusion Criteria:
- Initiated methadone at the study site in the past three months (and no less than two weeks prior to study enrollment) or demonstrated challenges with methadone adherence in the past three months as indicated by one or more of the following: a) at least one missing take-home bottle at the time of bottle return; b) screened negative for methadone in routinely administered clinic urinalysis tests; c) transitioned from an extended take-home bottle schedule to daily dosing schedule; or d) at least one missed methadone dose in the past 3 months as identified through clinic records
- Minimum of 18 years old
Exclusion Criteria:
- Demonstrating active, unstable or untreated psychiatric symptoms, including mania and/or psychosis that would interfere with study participation
- Inability to understand the study and provide informed consent in English
- Positive pregnancy status at enrollment
Sites / Locations
- University of Maryland Baltimore (UMD Drug Treatment Center)Recruiting
- University of Maryland College Park
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Peer-Delivered Behavioral Activation ("Peer Activate")
Treatment As Usual
Participants in the Peer Activate intervention will receive a PRS-delivered behavioral activation intervention to address barriers to retention in methadone treatment and increase substance-free, positive reinforcement to support retention.
Participants in the TAU group will receive treatment as usual (weekly group and individual counseling with an addiction counselor in addition to referral to other available services in the community through study contact).